We provide on going advices on a confidential basis to some of the world’s largest pharmaceutical and healthcare providers. Our experience includes advices to:

BioMarin Pharmaceuticals Inc on its agreement to buy a bulk biologics manufacturing plant from Pfizer for US$48.5m

The Sodexo Group on the purchase of a majority interest in Zehnacker Ireland Holdings Limited which will trade as Sodexo Zehnecker Healthcare

BiancaMed on its sale to ResMed, and on an on-going basis,  in the commercial exploitation of its patents with strategic partners including negotiating agreements with Omron Healthcare, a Japanese leader in healthcare solutions, Dorel Inc., one of the leading providers of healthcare solutions in the United States and iRhythm a leading international player in the cardiac rhythm monitoring sector

Olympus Corporation in the sale of its worldwide diagnostic systems business to biomedical test products maker, Beckman Coulter Inc, for a consideration of approximately €630 million. This was a multi-jurisdictional transaction that involved a complex pre-sale hive down restructuring

Trinity Biotech plc on the €66m sale of its diagnostic coagulation business to Stago International S.A.S.
Labcoat Limited, a development-stage drug-eluting stent technology company located in Galway, in relation to the acquisition of it by Boston Scientific Limited

Medfiq Healthcare Corporation in the acquisition of Medisize Medical (a division of the Swiss based Medisize Holding AG) a leading developer, manufacturer and distributor of dental consumables for a purchase price of €65 million

Ovation Pharmaceuticals Inc as Irish counsel in relation to its acquisition by H. Lundbeck A/S for consideration of up to US$900m

Astra Zeneca on the successful conclusion of the defence of its patent protecting its best-selling drug Nexium

Opsona Therapeutics on all commercial and funding matters relating to Opsona’s clinical development of lead drug candidate OPN-305 EU FP7 Project

Grunenthal Pharma, the German research-based pharmaceutical company, on a distribution agreement for pharma products

Millipore Corporation in connection with its €53bn global takeover by Merck KGaA

Millipore Corporation and Integra Life Sciences as lead Irish counsel advising each of them on all aspects of their legal requirements including corporate restructuring, licensing, commercial, intellectual property and tax advice

EirGen Pharma Limited in respect of ongoing commercial and patent advice

Crospon Limited on an innovative mix of high tech and biotech to produce an industry first skin patch that acts as a “smart” drug delivery device. This transaction between a smaller Irish medical device company and an IT industry giant has attracted significant international industry and media interest
Pfizer (Warner Lambert, a wholly-owned company of Pfizer) in its successful defence of its Lipitor patents, blocking generic production of its product until expiry. Lipitor is the world’s largest selling anti-cholesterol drug, which generates annual worldwide sales of €7.7bn.

View all

“Since EirGen Pharma was founded in 2005, we have worked very closely with David Carthy and his Life Sciences and Healthcare teams at William Fry. Most recently, William Fry have provided expert advice on company taxation planning coupled with advice on protection and use of EirGen’s intellectual property. Overall the service, delivery and knowledge of the pharmaceutical sector has been extremely beneficial to us in best protecting our interests and supporting our growth throughout all stages of EirGen’s evolution. I would thoroughly recommend David Carthy and the team at William Fry to any company in the Life Sciences sector and most especially to those entrepreneurs considering forming their own companies in this sector.”
Tom Brennan, Technical Director & Co-Founder, EirGen Pharma Limited

 

Carol Plunkett
Sources are effusive in their praise of outstanding contentious lawyer Carol Plunkett, with one saying: "She's one of the most experienced litigators in Dublin. Having dealt with cases across a huge spectrum, nothing will phase her at this stage." Another comments: "She is practical and knowledgeable, and understands commerciality. She manoeuvres around the issues very smoothly."
Chambers Global 2015 - Dispute Resolution

 

Carol Plunkett is a ‘seasoned litigator’ with 'great instincts'. 
Legal 500 EMEA, 2015

 

Carol Plunkett is described by clients as "hands-on and accessible, with excellent communication. She instils this culture in all her team and keeps everyone up to speed."
Chambers Global 2014 - Dispute Resolution

Carol Plunkett is widely acclaimed as “just brilliant. She has fantastic expertise in both intellectual property and commercial litigation.”
Chambers Global 2013 - Dispute Resolution

'Carol Plunkett complements her reputation as one of the leading IP litigators in the market with a substantial regulatory practice, and comes highly recommended by her clients.' 
Chambers Global, 2012

 

David Cullen
"An absolute expert and key leader," David Cullen "understands not only where our business is, but what our plans are, how we want to grow and what the consequences are," enthuse clients.
Chambers Europe, 2014 - Intellectual Property

David Cullen is a firm favourite with clients and is described as “calm and considered, with a wealth of knowledge about the area.”
Chambers Europe, 2013 - Intellectual Property

 

David Cullen is ‘one of the best in the business’.
Legal 500 EMEA, 2013

As well as winning plaudits for his technical ability, David Cullen is lauded as a 'superb negotiator. He can see around corners and anticipate the issues that will arise.'
Chambers Europe, 2012

 

David Cullen is ‘one of the best in the business’.
Legal 500 EMEA, 2012

 

David Carthy
David Carthy is  ‘knowledgeable’.
Legal 500 EMEA, 2015 - Corporate & Commercial

 

“Overall David was outstanding as our lead attorney and advisor.  His strengths included client relations, listening, communication skills, background of knowledge in healthcare, breadth of knowledge, ability to mobilize firm resources as necessary.  As lead partner for the engagement, David was integral to each aspect of the complex transaction.  His counsel, experience and negotiation skills are excellent.”
David Farner, Senior Vice President and Chief of Staff, UPMC